Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
Subscribe To Our Newsletter & Stay Updated
